生物活性 | |||
---|---|---|---|
描述 | Chiauranib (CS2164) is a multi-target inhibitor taken orally that acts against tumor angiogenesis. It effectively targets angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRα, and c-Kit), the mitosis-related kinase Aurora B, and the chronic inflammation-related kinase CSF-1R, with IC50 values between 1-9 nM, exhibiting potent anticancer effects[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.30mL 0.46mL 0.23mL |
11.48mL 2.30mL 1.15mL |
22.96mL 4.59mL 2.30mL |
参考文献 |
---|